Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Studies quality of life and care organization in people with chronic myeloid leukemia

Observes how hospital care models affect quality of life in adults with chronic myeloid leukemia.

Plain-language title generated from the registry record
Registry title: Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network

Key facts

Where
Monza, ItalySee the site

Where in Italy

  • Fondazione IRCCS San Gerardo dei TintoriMonza, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Milano Bicocca
Trial code
NCT07165535
Record updated
10 September 2025
Original description
The primary objective of the study is to assess the impact of the organizational model of the hematology center on the quality of life of patients with CML estimated through standardized tools (EORTC QLQ-30, CML24) and through the patient's opinion regarding aspects of the quality of care.Read full original descriptionShow less

Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network

The primary objective of the study is to assess the impact of the organizational model of the hematology center on the quality of life of patients with CML estimated through standardized tools (EORTC QLQ-30, CML24) and through the patient's opinion regarding aspects of the quality of care.

Inclusion: Subjects aged 18 years or older; Subjects diagnosed with Chronic Myeloid Leukemia; Subjects diagnosed with CML under care at the hematology outpatient clinics of the 21 REL centers; Subjects followed at the reference hematology center for a minimum of 6 months; Freely given informed consent obtained before the start of the study.

Exclusion: Subjects who have not given consent to participate in the study; Subjects who do not meet the inclusion criteria.

ClinicalTrials.gov NCT07165535